Open Your FREE Demat Account Now!

N/A
indicator

Nifty500 Healthcare Index

1D
1M
3M
6M
1Y
5Y
empty graph

Nifty500 Healthcare Index Performance

Low

₹20,418.05

High

₹20,731.30

52 Week Range

Low

₹17,164.05

High

₹22,125.15

Previous Close ₹20,478.35
Day's Range ₹20,418.05 - ₹20,731.30
Open ₹20,596.50
52 Week Range ₹17,164.05 - ₹22,125.15
Volume 3,88,08,716

Nifty500 Healthcare Index Companies

Company Name LTP (₹) Change (₹) Sector
Cipla Ltd. 1301.00 Arrow -5.80 (-0.44%) Healthcare
Dr. Reddy's Laboratories Ltd. 1197.00 Arrow 17.00 (1.44%) Healthcare
Lupin Ltd. 1956.50 Arrow 19.60 (1.01%) Healthcare
Torrent Pharmaceuticals Ltd. 4656.90 Arrow 39.80 (0.86%) Healthcare
Abbott India Ltd. 26000.00 Arrow 420.00 (1.64%) Healthcare
Glaxosmithkline Pharmaceuticals Ltd. 2540.30 Arrow 5.90 (0.23%) Healthcare
Apollo Hospitals Enterprise Ltd. 8027.50 Arrow 361.50 (4.72%) Healthcare
Ipca Laboratories Ltd. 1915.40 Arrow -23.00 (-1.19%) Healthcare
Neuland Laboratories Ltd. 20890.00 Arrow -125.00 (-0.59%) Healthcare
Sun Pharmaceutical Industries Ltd. 1760.00 Arrow 0.20 (0.01%) Healthcare

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 22520.45 26373.20 22179.90
Nifty IT 28574.9 40301.40 25699.10
Nifty Next 50 68166.7 75000.40 59896.10
NIFTY50 USD Index 8068.1 10443.40 7839.85
Nifty Bank 55256.65 61764.85 49954.85
NIFTY Midcap 100 58787.3 64450.90 52032.85
Nifty 500 21866.65 24144.20 20385.65
Nifty Midcap 50 16786.7 18500.95 14804.55
Nifty 100 23547.9 26975.15 22720.45
Nifty FMCG 44864.25 57445.20 43442.30

Latest News

Oct
9
2026
EQUITY Posted on Oct 9th 2026

Torrent Pharmaceuticals submits analyst meet intimation

Torrent Pharmaceuticals has informed that the Company has scheduled a teleconference with Investors/ Analysts on 23rd October, 2026 at 05:30 PM to discuss the financial performance of the Company for the quarter and half year ended 30th September, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
9
2026
EQUITY Posted on Oct 9th 2026

Aurobindo Pharma informs about newspaper publication

Aurobindo Pharma has enclosed the copies of notice published by the Company on October 9, 2026, in Business Standard and Nava Telangana (Telugu) regarding special window for re-lodgement of transfer requests of physical shares.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Cohance Lifesciences informs about ESG rating

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’), read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026, Cohance Lifesciences has informed that Crisil ESG Ratings & Analytics (Crisil ESG Ratings) has voluntarily assigned an ESG Rating of ‘Crisil ESG 61 (Strong)’ and Core ESG Rating of ‘Crisil Core ESG 67 (Strong)’ to the Company. The link for the rating as published by Crisil ESG Ratings: https://www.crisilesg.com/en/home/esg-ratings.html. The Company has not engaged Crisil ESG Ratings for the ESG Rating. The rating has been independently determined by Crisil ESG Ratings based on publicly available information pertaining to the Company. 

The above information is a part of company’s filings submitted to BSE. 

Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Lupin informs about press release

Lupin has informed that it enclosed a Press Release titled ‘Lupin Launches Formoflo-G® MDI, World’s First Fixed-dose Triple Combination Drug for COPD Management’.
The above information is a part of company’s filings submitted to BSE. 
Read More
Oct
6
2026
EQUITY Posted on Oct 6th 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Adapalene Gel USP, 0.1% (OTC) in new pump packs. Glenmark’s Adapalene Gel USP, 0.1% can be compared to the active ingredient of Differin®2 Gel, 0.1%. According to Nielsen® syndicated data for the latest 52-week period ending September 5, 2026, the Differin® Gel, 0.1% (OTC) market3 achieved annual sales of approximately $45.8 million*. The company has attached media release in this regard. 
The above information is a part of company’s filings submitted to BSE. 
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NFT500HEALTH index?

The previous close of NFT500HEALTH index is ₹20679.4 as of 2026-10-09.

The total volume of NFT500HEALTH index is 38789524.00 as of 2026-10-09.

The percentage change in value of NFT500HEALTH index is 0.98% as of 2026-10-09.

The absolute increase in NFT500HEALTH index value since the previous trading day is ₹201.05 as of 2026-10-09.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More

People Also Ask

What defines the Nifty 500 Healthcare Index?

The Nifty 500 Healthcare Index is a sectoral index that tracks selected healthcare companies from the Nifty 500 universe. It represents listed businesses across healthcare delivery, pharmaceuticals, diagnostics, biotechnology, medical services, and related segments.

Companies are selected from healthcare-sector stocks within the Nifty 500 universe based on NSE Indices' methodology and industry classification. The index is reviewed periodically in accordance with the index maintenance methodology.

The Nifty 500 Healthcare Index is calculated using the free-float market capitalisation method. This approach considers only publicly available shares while assigning weights to eligible healthcare companies within the index.

The Nifty 500 Healthcare Index includes companies from pharmaceuticals, hospitals, diagnostics, biotechnology, healthcare services, medical equipment, and related healthcare businesses listed within the broader Nifty 500 universe.

Yes, hospitals, diagnostics, and pharmaceutical companies may be part of the Nifty 500 Healthcare Index if they meet the index provider’s eligibility rules. The index is designed to capture different areas of India’s healthcare sector.

The Nifty 500 Healthcare Index measures the performance of healthcare-sector companies included in the Nifty 500 universe. It reflects the market performance of listed companies engaged in areas such as pharmaceuticals, hospitals, diagnostics, biotechnology, medical equipment, and other healthcare-related businesses.

The Nifty 500 Healthcare Index is reviewed and rebalanced periodically in accordance with NSE Indices' index maintenance methodology. The review helps ensure that the index continues to reflect eligible healthcare companies within the Nifty 500 universe.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore